|
Volumn 29, Issue 4, 2009, Pages 391-392
|
Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: A case report
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
HALOPERIDOL;
LORAZEPAM;
RISPERIDONE;
ACUTE PANCREATITIS;
ADULT;
ANAMNESIS;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
HYPERAMYLASEMIA;
HYPERLIPASEMIA;
INBORN ERROR OF METABOLISM;
LETTER;
MENTAL DISEASE;
MORBIDITY;
MORTALITY;
NASOGASTRIC TUBE;
NEUROLEPTIC MALIGNANT SYNDROME;
NEUROLOGIC EXAMINATION;
PRIORITY JOURNAL;
RHABDOMYOLYSIS;
RISK ASSESSMENT;
SCHIZOPHRENIA;
SURGICAL TECHNIQUE;
ANTIPSYCHOTIC AGENTS;
FEMALE;
HUMANS;
HYPERAMYLASEMIA;
INJECTIONS, INTRAMUSCULAR;
INTUBATION, GASTROINTESTINAL;
LIPASE;
LORAZEPAM;
MIDDLE AGED;
NEUROLEPTIC MALIGNANT SYNDROME;
PANCREATITIS;
RISPERIDONE;
SCHIZOPHRENIA, DISORGANIZED;
TREATMENT OUTCOME;
URINARY CATHETERIZATION;
|
EID: 68449104856
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/JCP.0b013e3181ad2064 Document Type: Letter |
Times cited : (5)
|
References (9)
|